Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

NCT00273299 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

607

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: valsartan plus hydrochlorothiazide

Sponsor

Novartis